The mission of the DF/HCC Ovarian SPORE Tissue Bank and Pathology Core is to maximize the research use of clinical specimens available from DF/HCC patients in a confidential and ethical manner, provide state of the art research pathology services and expert morphologic interpretation of tissue slides and to maximize the cost effectiveness and quality of these research pathology services to the SPORE investigators and qualified investigators at other institutions. This mission will be achieved through the following specific aims: 1) Catalog existing operative tissue and clinical specimen banks at BIDMC, BWH, DFCI, and MGH and organize them to be uniform 2) Expand clinical specimen collection at BIDMC, BWH, and DFCI 3) Assure that all specimen collection occurs and data is stored and shared under approved human subjects and other regulatory guidelines. 4) Create the infrastructure for a """"""""virtually-unified"""""""" ovarian specimen bank able to identify and supply specimens needed for a particular research project together with the level of clinical identifiers appropriate for the project. 5) Provide research pathology services to SPORE investigators. Existing banks at DFCI already provide a variety of high quality clinical specimens including snap frozen and frozen OCT-embedded ovarian and normal tissue suitable for retrieval of DNA and RNA, fixed paraffin embedded ovarian and normal tissue, and frozen blood components, body fluids and urine. To maximize their suitability and availability for research, collection and storage methods will be made uniform and the specimens catalogued. Collection of clinical specimens occurring at MGH and DFCI will be expanded to other DF/HCC institutions under rigorous human subject's guidelines. To achieve the critical goal to create a """"""""virtually-unified"""""""" bank, data collection methods will be standardized and a secure, centralized database created. A governance system will be established to permit a fair, timely evaluation of requests for research materials with determination of level of linkage to clinical data permitted by the informed consent agreements. The DF/HCC Tissue Core will be lead by pathologists and clinical researchers who have a track record of collaborative research documented by nearly 70 joint publications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA105009-05
Application #
7690259
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2008
Total Cost
$253,278
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Earp, Madalene; Tyrer, Jonathan P; Winham, Stacey J et al. (2018) Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS One 13:e0197561
Harris, Holly R; Rice, Megan S; Shafrir, Amy L et al. (2018) Lifestyle and Reproductive Factors and Ovarian Cancer Risk by p53 and MAPK Expression. Cancer Epidemiol Biomarkers Prev 27:96-102
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun et al. (2018) Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol 187:366-377
Ong, Jue-Sheng; Hwang, Liang-Dar; Cuellar-Partida, Gabriel et al. (2018) Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol 47:450-459
Dixon, Suzanne C; Nagle, Christina M; Wentzensen, Nicolas et al. (2017) Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Br J Cancer 116:1223-1228
Elias, Kevin M; Fendler, Wojciech; Stawiski, Konrad et al. (2017) Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife 6:
Praestegaard, Camilla; Jensen, Allan; Jensen, Signe M et al. (2017) Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer 140:2422-2435

Showing the most recent 10 out of 221 publications